Company Name

Industry

Location

Revenue

Employees

StemCells

Biotechnology

United States, Delaware

$50M to $100M

51-200

HilleVax

Biotechnology

United States, Massachusetts

$50M to $100M

51-200

Omixon

Biotechnology

United States, Georgia

$50M to $100M

51-200

Verastem Oncology

Biotechnology

United States, Massachusetts

$50M to $100M

51-200

Agendia

Biotechnology

United States, California

$50M to $100M

51-200

Genalyte

Biotechnology

United States, California

$50M to $100M

51-200

Geno

Biotechnology

United States, California

$50M to $100M

51-200

Malden High School

Biotechnology

United States, Missouri

$50M to $100M

51-200

Genocea

Biotechnology

United States, Massachusetts

$50M to $100M

51-200

Fluid Management Systems

Biotechnology

United States, Massachusetts

$50M to $100M

51-200

CARR Biosystems

Biotechnology

United States, Florida

$50M to $100M

51-200

Integrium

Biotechnology

United States, California

$50M to $100M

51-200

FHC

Biotechnology

United States, Maine

$50M to $100M

51-200

Psomagen

Biotechnology

United States, Maryland

$50M to $100M

51-200

Seer

Biotechnology

United States, California

$50M to $100M

51-200

Mission Bio

Biotechnology

United States, California

$50M to $100M

51-200

ChemImage Corporation

Biotechnology

United States, Pennsylvania

$50M to $100M

51-200

Tetraphase Pharmaceuticals

Biotechnology

United States, Massachusetts

$50M to $100M

51-200

Sutter Instrument

Biotechnology

United States, California

$50M to $100M

51-200

NextCure

Biotechnology

United States, Maryland

$50M to $100M

51-200